Literature DB >> 23694797

Cholangiocarcinoma: risk factors, environmental influences and oncogenesis.

Redha Al-Bahrani1, Yasser Abuetabh, Nikolas Zeitouni, Consolato Sergi.   

Abstract

Cholangiocarcinoma (CCA) is one of the most frequent malignant epithelial liver tumors after hepatocellular carcinoma (HCC). Its incidence seems to be increasing worldwide, although risk factors are heterogeneous and differ globally. Although diagnostic and therapeutic medicine have advanced in several countries, tackling this tumor remains a challenge. The causes of CCA's increasing incidence are likely a differential increment of some factors according to the geographical area, which will be considered in this review. Environment-linked risk factors may play a critical role in the carcinogenesis. Liver flukes may play a major role in East Asia, while exposure to chemical compounds, such as naphthenic acids, has been postulated as a source of the rate increase in Western countries. Carcinogenesis is variable and confounding factors also need to be taken into account. Carcinogenesis depends on a sequential process and most probably involves both cholestasis and chronic inflammation as promoting steps after induction. The release and interaction of interleukin-6 (IL-6), transforming growth factor beta (TGF-beta), tumor necrosis factor alpha (TNF-alpha), and platelet-derived growth factor (PDGF) are at the basis of the proliferation of biliary epithelial cells or cholangiocytes. Additional steps for the final development of CCA may also involve an increase of the mutation rate of tumor suppressor genes, such as TP53, and the evasion of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23694797

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  28 in total

1.  Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line.

Authors:  Runping Liu; Xiaojiaoyang Li; Xiaoyan Qiang; Lan Luo; Phillip B Hylemon; Zhenzhou Jiang; Luyong Zhang; Huiping Zhou
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

Review 2.  Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.

Authors:  Neda Amini; Aslam Ejaz; Gaya Spolverato; Shishir K Maithel; Yuhree Kim; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-10-10       Impact factor: 3.452

3.  Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Redha Al-Bahrani; Seishi Nagamori; Roger Leng; Anna Petryk; Consolato Sergi
Journal:  Pathol Oncol Res       Date:  2015-03-05       Impact factor: 3.201

Review 4.  Cholangiocarcinoma: from molecular biology to treatment.

Authors:  Ana F Brito; Ana M Abrantes; João C Encarnação; José G Tralhão; Maria F Botelho
Journal:  Med Oncol       Date:  2015-10-01       Impact factor: 3.064

5.  Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo.

Authors:  Youyou Qin; Wu Cui; Xuewei Yang; Baifeng Tong
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-15       Impact factor: 3.848

Review 6.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

Review 7.  A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.

Authors:  Sebastian Rasch; Hana Algül
Journal:  Clin Exp Gastroenterol       Date:  2014-08-11

8.  Mitochondriome and cholangiocellular carcinoma.

Authors:  Wesam Bahitham; Xiaoping Liao; Fred Peng; Fiona Bamforth; Alicia Chan; Andrew Mason; Bradley Stone; Paul Stothard; Consolato Sergi
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

9.  Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.

Authors:  Runping Liu; Renping Zhao; Xiqiao Zhou; Xiuyin Liang; Deanna J W Campbell; Xiaoxuan Zhang; Luyong Zhang; Ruihua Shi; Guangji Wang; William M Pandak; Alphonse E Sirica; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

10.  Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.

Authors:  Yue Gu; Linfeng Xiao; Yanlin Ming; Zhizhong Zheng; Wengang Li
Journal:  Int J Oncol       Date:  2016-03-02       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.